Alimentary Pharmacology and Therapeutics, 0269-2813

Journal

More filtering options
  1. 2019
  2. Letter: different risks of venous thromboembolism in subsets of patients with inflammatory bowel diseases

    Ding, R., Xu, J., He, Z., Yihong Chen, Anna Hultgårdh-Nilsson & Liang, C., 2019, In : Alimentary Pharmacology and Therapeutics. 49, 3, p. 345-346 2 p.

    Research output: Contribution to journalLetter

  3. 2017
  4. Letter: how to define remission in ulcerative colitis – histological remission should be considered. Authors' reply

    Angelison, L., Marsal, J. & Hertervig, E., 2017 Apr 1, In : Alimentary Pharmacology and Therapeutics. 45, 8, p. 1177-1178 2 p.

    Research output: Contribution to journalLetter

  5. Long-term outcome of infliximab treatment in chronic active ulcerative colitis: a Swedish multicentre study of 250 patients

    Angelison, L., Almer, S., Eriksson, A., Karling, P., Fagerberg, U., Halfvarson, J., Thörn, M., Björk, J., Hindorf, U., Löfberg, R., Bajor, A., Hjortswang, H., Hammarlund, P., O. Grip, Torp, J., Marsal, J. & Hertervig, E., 2017 Feb 1, In : Alimentary Pharmacology and Therapeutics. 45, 4, p. 519-532 14 p.

    Research output: Contribution to journalArticle

  6. 2016
  7. Incidence, clinical presentation and mortality of liver cirrhosis in Southern Sweden: A 10-year population-based study

    NILSSON, EMMA., Anderson, H., K. Sargenti, S. Lindgren & H. Prytz, 2016 Jun 1, In : Alimentary pharmacology & therapeutics. 43, 12, p. 1330-1339 10 p.

    Research output: Contribution to journalArticle

  8. 2014
  9. Association between high dietary intake of the n-3 polyunsaturated fatty acid docosahexaenoic acid and reduced risk of Crohn's disease

    Chan, S. S. M., Luben, R., Olsen, A., Tjonneland, A., Kaaks, R., Stefan Lindgren, Olof Grip, Bergmann, M. M., Boeing, H., Hallmans, G., Karling, P., Overvad, K., Veno, S. K., van Schaik, F., Bueno-de-Mesquita, B., Oldenburg, B., Khaw, K. -T., Riboli, E. & Hart, A. R., 2014, In : Alimentary pharmacology & therapeutics. 39, 8, p. 834-842

    Research output: Contribution to journalArticle

  10. Letter: European Medicines Agency recommendations for allergic reactions to intravenous iron-containing medicines

    Gomollon, F., Chowers, Y., Danese, S., Dignass, A., Nielsen, O. H., Lakatos, P. L., Lees, C. W., Stefan Lindgren, Lukas, M., Mantzaris, G. J., Michetti, P., Moum, B., Peyrin-Biroulet, L., Toruner, M., van der Woude, J., Weiss, G., Stoevelaar, H. & Reinisch, W., 2014, In : Alimentary pharmacology & therapeutics. 39, 7, p. 743-744

    Research output: Contribution to journalLetter

  11. 2013
  12. Infliximab as rescue therapy in hospitalised patients with steroid-refractory acute ulcerative colitis: a long-term follow-up of 211 Swedish patients

    Sjoberg, M., Magnuson, A., Bjork, J., Cecilia Benoni, Almer, S., Friis-Liby, I., Erik Hertervig, Olsson, M., Karlen, P., Eriksson, A., Midhagen, G., Carlson, M., Lapidus, A., Halfvarson, J. & Tysk, C., 2013, In : Alimentary pharmacology & therapeutics. 38, 4, p. 377-387

    Research output: Contribution to journalArticle

  13. The management of iron deficiency in inflammatory bowel disease - an online tool developed by the RAND/UCLA appropriateness method

    Reinisch, W., Chowers, Y., Danese, S., Dignass, A., Gomollon, F., Nielsen, O. H., Lakatos, P. L., Lees, C. W., Stefan Lindgren, Lukas, M., Mantzaris, G. J., Michetti, P., Moum, B., Peyrin-Biroulet, L., Toruner, M., van der Woude, J., Weiss, G. & Stoevelaar, H., 2013, In : Alimentary pharmacology & therapeutics. 38, 9, p. 1109-1118

    Research output: Contribution to journalArticle

  14. 2012
  15. Fatigue in out-patients with inflammatory bowel disease is common and multifactorial.

    Bager, P., Befrits, R., Wikman, O., Stefan Lindgren, Moum, B., Hjortswang, H., Hjollund, N. H. & Dahlerup, J. F., 2012, In : Alimentary pharmacology & therapeutics. 35, p. 133-141

    Research output: Contribution to journalArticle

  16. High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia

    Lindstrom, L., Boberg, K. M., Wikman, O., Friis-Liby, I., Hultcrantz, R., Hanne Prytz, Sandberg-Gertzen, H., Sangfelt, P., Rydning, A., Folvik, G., Gangsoy-Kristiansen, M., Danielsson, A. & Bergquist, A., 2012, In : Alimentary pharmacology & therapeutics. 35, 4, p. 451-457

    Research output: Contribution to journalArticle

  17. 2011
  18. Hospitalisation of and mortality from bleeding peptic ulcer in Sweden: a nationwide time-trend analysis.

    Åhsberg, K., Ye, W., Lu, Y., Zheng, Z. & Christer Staël von Holstein, 2011, In : Alimentary pharmacology & therapeutics. 33, 5, p. 578-584

    Research output: Contribution to journalArticle

  19. 2010
  20. Clinical trial: colectomy after rescue therapy in ulcerative colitis-3-year follow-up of the Swedish-Danish controlled infliximab study

    Gustavsson, A., Jarnerot, G., Erik Hertervig, Friis-Liby, I., Blomquist, L., Karlen, P., Granno, C., Vilien, M., Strom, M., Verbaan, H., Hellstrom, P. M., Magnuson, A., Halfvarson, J. & Tysk, C., 2010, In : Alimentary pharmacology & therapeutics. 32, 8, p. 984-989

    Research output: Contribution to journalArticle

  21. 2009
  22. Bleeding peptic ulcer - time trends in incidence, treatment and mortality in Sweden.

    Sadic, J., Borgström, A., Jonas Manjer, Toth, E. & Lindell, G., 2009, In : Alimentary pharmacology & therapeutics. 30, p. 392-398

    Research output: Contribution to journalArticle

  23. Clinical trial: B vitamins improve health in patients with coeliac disease living on a gluten-free diet

    Hallert, C., Svensson, M., Tholstrup, J. & Hultberg, B., 2009, In : Alimentary pharmacology & therapeutics. 29, 8, p. 811-816

    Research output: Contribution to journalArticle

  24. Mercaptopurine treatment should be considered in azathioprine intolerant patients with inflammatory bowel disease.

    Hindorf, U., Johansson, M., Eriksson, A., Kvifors, E. & Almer, S. H. C., 2009, In : Alimentary pharmacology & therapeutics. 29, 6, p. 654-661

    Research output: Contribution to journalArticle

  25. 2006
  26. Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease.

    Hindorf, U., Lindqvist, M., Hildebrand, H., Fagerberg, U. & Almer, S., 2006, In : Alimentary pharmacology & therapeutics. 24, 2, p. 331-342

    Research output: Contribution to journalArticle

  27. 2005
  28. Daily treatment with esomeprazole is superior to that taken on demand for maintenance of healed erosive esophagitis

    Sjöstedt, S., Befrits, R., Sylvan, A., Carling, L., Harthon, C., Modin, S., Stubberöd, A. & Toth, E., 2005, In : Alimentary pharmacology & therapeutics. 22, 3, p. 183-191

    Research output: Contribution to journalArticle

  29. 2004
  30. Helicobacter species in human colon biopsies

    Erik Sturegård, Erik Hertervig, Sjunnesson, H. & Wadström, T., 2004, In : Alimentary pharmacology & therapeutics. 19, 5, p. 613-614

    Research output: Contribution to journalLetter

  31. 2003
  32. A pharmacoscintigraphic evaluation of oral budesonide given as controlled-release (Entocort) capsules.

    Edsbäcker, S., Bengtsson, B., Larsson, P., Lundin, P., Nilsson, A., Ulmius, J. & Per Wollmer, 2003, In : Alimentary pharmacology & therapeutics. 17, 4, p. 525-536

    Research output: Contribution to journalArticle